FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Livingston

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Brenda F Kurland; Kimberly H Allison; Xiaoyu Chai; Vijayakrishna K Gadi; Robert B Livingston; David A Mankoff; Lanell M Peterson; Eve T Rodler; Erin K Schubert; Jennifer M Specht; Hannah M Linden
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients.
Anne F Schott; James L Wade; Keith S Lanier; Danika L Lew; Robert B Livingston; Kathy S Albain; William E Barlow; Helen K Chew; Julie R Gralow; Daniel F Hayes; Gabriel N Hortobagyi
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.
Lara E Sucheston; G Thomas Budd; Song Yao; Hua Zhao; Gary Zirpoli; Kathy S Albain; William E Barlow; Gregory L Ciupak; Warren Davis; Julie R Gralow; Daniel F Hayes; Dawn L Hershman; Timothy J Hobday; Gabriel N Hortobagyi; Claudine Isaacs; Song Liu; Robert B Livingston; Halle C F Moore; Muhammad Salim; James A Stewart; Christine B Ambrosone
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Livingston (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Brenda F Kurland; Kimberly H Allison; Xiaoyu Chai; Vijayakrishna K Gadi; Robert B Livingston; David A Mankoff; Lanell M Peterson; Eve T Rodler; Erin K Schubert; Jennifer M Specht; Hannah M Linden
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients.
EJNMMI research 2012;2(1):34.
2012: Anne F Schott; James L Wade; Keith S Lanier; Danika L Lew; Robert B Livingston; Kathy S Albain; William E Barlow; Helen K Chew; Julie R Gralow; Daniel F Hayes; Gabriel N Hortobagyi
Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430.
The oncologist 2012;17(2):179-87.
2011: Lara E Sucheston; G Thomas Budd; Song Yao; Hua Zhao; Gary Zirpoli; Kathy S Albain; William E Barlow; Gregory L Ciupak; Warren Davis; Julie R Gralow; Daniel F Hayes; Dawn L Hershman; Timothy J Hobday; Gabriel N Hortobagyi; Claudine Isaacs; Song Liu; Robert B Livingston; Halle C F Moore; Muhammad Salim; James A Stewart; Christine B Ambrosone
Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221).
Breast cancer research and treatment 2011;130(3):993-1002.
2011: Hannah M Linden; Jeanne M Link; Robert B Livingston; Georgiana K Ellis; Julie R Gralow; Kenneth A Krohn; Brenda F Kurland; Thomas J Lawton; Lanell M Peterson; Philip H Petra; Erin K Schubert; Jennifer M Specht; David A Mankoff
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(14):4799-805.
2009: Kathy S Albain; William E Barlow; Peter M Ravdin; William B Farrar; Gary V Burton; Steven J Ketchel; Charles D Cobau; Ellis G Levine; James N Ingle; Kathleen I Pritchard; Allen S Lichter; Daniel J Schneider; Martin D Abeloff; I Craig Henderson; Hyman Muss; Stephanie J Green; Danika Lew; Robert B Livingston; Silvana Martino; C Kent Osborne
Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.
Lancet 2009;374(9707):2055-63.
2008: Andrea Bezjak; Christopher W Lee; Keyue Ding; Michael D Brundage; Timothy Winton; Barbara Graham; Marlo Whitehead; David H Johnson; Robert B Livingston; Lesley Seymour; Frances A Shepherd
Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5052-9.
2008: Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Robert B Livingston; Hannah M Linden; Jennifer M Specht; Robert K Doot; Thomas Lawton; William E Barlow; Brenda F Kurland; Erin K Schubert; David A Mankoff
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(27):4449-57.
2008: Deborah T Blumenthal; Cathryn Rankin; Harmon J Eyre; Robert B Livingston; Alexander M Spence; Keith J Stelzer; Elisabeth J Rushing; Mitchel S Berger; Saul E Rivkin; Allen L Cohn; Stephen H Petersdorf
External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.
Cancer 2008;113(3):559-65.
2007: Jennifer M Specht; Stephen L Tam; Brenda F Kurland; Julie R Gralow; Robert B Livingston; Hannah M Linden; Georgiana K Ellis; Erin K Schubert; Lisa K Dunnwald; David A Mankoff
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).
Breast cancer research and treatment 2007;105(1):87-94.
2007: Jeffrey P Kanne; David A Mankoff; Geoffrey S Baird; Satoshi Minoshima; Robert B Livingston
Gastric linitis plastica from metastatic breast carcinoma: FDG and FES PET appearances.
AJR. American journal of roentgenology 2007;188(6):W503-5.
2007: Halle C F Moore; Stephanie J Green; Julie R Gralow; Scott I Bearman; Danika Lew; William E Barlow; Clifford Hudis; Antonio C Wolff; James N Ingle; Helen K Chew; Anthony D Elias; Robert B Livingston; Silvana Martino
Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(13):1677-82.
2007: Hannah M Linden; Charles M Haskell; Stephanie J Green; C Kent Osborne; George W Sledge; Charles L Shapiro; James N Ingle; Danika Lew; Laura F Hutchins; Robert B Livingston; Silvana Martino
Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):656-61.
2007: Valerie W Rusch; Dorothy J Giroux; Michael J Kraut; John Crowley; Mark Hazuka; Timothy Winton; David H Johnson; Lawrence Shulman; Frances A Shepherd; Claude Deschamps; Robert B Livingston; David R Gandara
Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):313-8.
2006: Peggy L Porter; William E Barlow; I-Tien Yeh; Ming Gang Lin; Xiaopu P Yuan; Elizabeth Donato; George W Sledge; Charles L Shapiro; James N Ingle; Charles M Haskell; Kathy S Albain; James M Roberts; Robert B Livingston; Daniel F Hayes
p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy.
Journal of the National Cancer Institute 2006;98(23):1723-31.
2006: Hannah M Linden; Kenneth A Krohn; Robert B Livingston; David A Mankoff
Monitoring targeted therapy: is fluorodeoxylucose uptake a marker of early response?
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5608-10.
2006: Hannah M Linden; Svetlana A Stekhova; Jeanne M Link; Julie R Gralow; Robert B Livingston; Georgiana K Ellis; Philip H Petra; Lanell M Peterson; Erin K Schubert; Lisa K Dunnwald; Kenneth A Krohn; David A Mankoff
Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2793-9.
2006: Joseph M Unger; Charles A Coltman; John J Crowley; Laura F Hutchins; Silvana Martino; Robert B Livingston; John S Macdonald; Charles D Blanke; David R Gandara; E David Crawford; Kathy S Albain
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):141-4.
2005: Howard L West; John J Crowley; R B Vance; Wilbur A Franklin; Robert B Livingston; Shaker R Dakhil; Jeffrey K Giguere; Saul E Rivkin; M Kraut; Kari Chansky; David R Gandara
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1076-80.
2005: Laurie E Gaspar; Kari Chansky; Kathy S Albain; Eric Vallieres; Valerie W Rusch; John J Crowley; Robert B Livingston; David R Gandara
Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2955-61.
2005: Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Robert B Livingston; Hannah M Linden; Thomas Lawton; William E Barlow; Erin K Schubert; David A Mankoff
Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival.
Cancer 2005;103(4):680-8.
2005: Lori J Pierce; Laura F Hutchins; Stephanie R Green; Danika L Lew; Julie R Gralow; Robert B Livingston; C Kent Osborne; Kathy S Albain
Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):24-9.
2004: Xiaoming Chen; Mark O Moore; Constance D Lehman; David A Mankoff; Thomas Lawton; Sue Peacock; Erin K Schubert; Robert B Livingston
Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy.
Academic radiology 2004;11(10):1115-24.
2004: Jennifer Bellon; Robert B Livingston; William B Eubank; Julie R Gralow; Georgiana K Ellis; Lisa K Dunnwald; David A Mankoff
Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC).
American journal of clinical oncology 2004;27(4):407-10.
2004: Jeannine S McCune; Amy J Hatfield; Anne A R Blackburn; Patricia O Leith; Robert B Livingston; Georgiana K Ellis
Potential of chemotherapy-herb interactions in adult cancer patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(6):454-62.
2004: Hadi Yaziji; Lynn C Goldstein; Todd S Barry; Robert W Werling; Harry Hwang; Georgiana K Ellis; Julie R Gralow; Robert B Livingston; Allen M Gown
HER-2 testing in breast cancer using parallel tissue-based methods.
JAMA : the journal of the American Medical Association 2004;291(16):1972-7.
2003: David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Erin K Schubert; Jeffrey Tseng; Thomas Lawton; Hannah M Linden; Robert B Livingston
Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(11):1806-14.
2003: Tina W F Yen; Gary N Mann; Thomas Lawton; Robert B Livingston; Benjamin O Anderson
An axillary recurrence of breast cancer following a negative sentinel lymph node biopsy.
The breast journal 2003;9(3):234-6.
2003: Julie A Garrison; Jeannine S McCune; Robert B Livingston; Hannah M Linden; Julie R Gralow; Georgiana K Ellis; Howard L West
Myalgias and arthralgias associated with paclitaxel.
Oncology (Williston Park, N.Y.) 2003;17(2):271-7; discussion 281-2, 286-8.
2002: David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Erin K Schubert; Aaron W Charlop; Jeffrey Tseng; Kristine J Rinn; Robert B Livingston
[Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow.
Nuclear medicine and biology 2002;29(7):719-27.
2002: Georgiana K Ellis; Robert B Livingston; Julie R Gralow; Stephanie J Green; Tove Thompson
Dose-dense anthracycline-based chemotherapy for node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(17):3637-43.
2002: Kathy S Albain; John J Crowley; Andrew T Turrisi; David R Gandara; William B Farrar; Joseph I Clark; Kristie R Beasley; Robert B Livingston
Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3454-60.
2002: Stephanie E Stafford; Julie R Gralow; Erin K Schubert; Kristine J Rinn; Lisa K Dunnwald; Robert B Livingston; David A Mankoff
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.
Academic radiology 2002;9(8):913-21.
2002: David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Aaron W Charlop; Thomas Lawton; Erin K Schubert; Jeffrey Tseng; Robert B Livingston
Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(4):500-9.
2002: William B Eubank; David A Mankoff; Hubert Vesselle; Janet F Eary; Erin K Schubert; Lisa K Dunnwald; Skyler K Lindsley; Julie R Gralow; Mary Austin-Seymour; Georgiana K Ellis; Robert B Livingston
Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET.
Radiographics : a review publication of the Radiological Society of North America, Inc 2002;22(1):5-17.
2001: J R Gralow; Robert B Livingston
University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: unexpected cardiac toxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18):3903-4.
2001: Charles Thomas; Dorothy J Giroux; L M Janaki; A T Turrisi; John J Crowley; Sarah A Taylor; J D McCracken; P G Shankir Giri; W Gordon; Robert B Livingston; David R Gandara
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;33(2-3):213-9.
2001: Karen Kelly; L Lovato; Paul A Bunn; Robert B Livingston; J Zangmeister; Sarah A Taylor; D Roychowdhury; J J Crowley; David R Gandara
Cisplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in untreated patients with extensive-stage small cell lung cancer: a phase II trial of the Southwest Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2325-9.
2001: William B Eubank; David A Mankoff; Julie E Takasugi; Hubert Vesselle; Janet F Eary; Thomas P Shanley; Julie R Gralow; Aaron W Charlop; Georgiana K Ellis; KL Lindsley; Mary Austin-Seymour; C P Funkhouser; Robert B Livingston
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3516-23.
2001: Karen Kelly; J Crowley; Paul A Bunn; Cary A Presant; Patra Grevstad; Carol M Moinpour; Scott D Ramsey; Antoinette J Wozniak; Geoffrey R Weiss; D F Moore; Valerie K Israel; Robert B Livingston; David R Gandara
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(13):3210-8.
2000: Jennifer Bellon; KL Lindsley; Georgiana K Ellis; Julie R Gralow; Robert B Livingston; Mary Austin-Seymour
Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer.
International journal of radiation oncology, biology, physics 2000;48(2):393-7.
1999: Georgiana K Ellis; S Green; Robert B Livingston; M J Kraut; HI Pierce; J C Paradelo; Sarah A Taylor; S Martino
'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II Study.
American journal of clinical oncology 1999;22(5):446-9.
1999: Nevin Murray; Robert B Livingston; Frances A Shepherd; K James; Benny Zee; A Langleben; Michael J Kraut; James Bearden; J Wendall Goodwin; C Grafton; A Turrisi; D Walde; H Croft; David Osoba; Jon Ottaway; David R Gandara
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2300-8.
1999: B R Leigh; David R Gandara; J J Crowley; K Furuse; Robert B Livingston; M Fukushima; Charles A Coltman
Summary of the proceedings of the United States--Japan lung cancer clinical trials summit: San Francisco, CA, 20-22 November, 1998.
Lung cancer (Amsterdam, Netherlands) 1999;24(3):181-91.
1999: David A Mankoff; Lisa K Dunnwald; Julie R Gralow; Georgiana K Ellis; Mariann J Drucker; Robert B Livingston
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
Cancer 1999;85(11):2410-23.
1999: Georgiana K Ellis; Julie R Gralow; HI Pierce; M A Williams; Robert B Livingston
Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(5):1407-12.
1998: Derick H Lau; John J Crowley; David R Gandara; Mark Hazuka; Kathy S Albain; Bryan R Leigh; W S Fletcher; Keith S Lanier; W L Keiser; Robert B Livingston
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3078-81.
1998: Antoinette J Wozniak; John J Crowley; Stanley P Balcerzak; Geoffrey R Weiss; C Harris Spiridonidis; Laurence H Baker; Kathy S Albain; Karen Kelly; Sarah A Taylor; David R Gandara; Robert B Livingston
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2459-65.
1998: Charles Thomas; Dorothy J Giroux; Keith J Stelzer; J B Craig; L R Laufman; Sarah A Taylor; J Wendall Goodwin; John J Crowley; Robert B Livingston
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
International journal of radiation oncology, biology, physics 1998;40(5):1039-47.
1997: Robert B Livingston
Combined modality therapy of lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 2):2638-47.
1997: P N Grozea; J J Crowley; Vikki A Canfield; L Kingsbury; S W Ross; G S Beltran; L R Laufman; G R Weiss; Robert B Livingston
Teniposide (VM-26) as a single drug treatment for patients with extensive small cell lung carcinoma: a Phase II study of the Southwest Oncology Group.
Cancer 1997;80(6):1029-33.
1997: Robert B Livingston; Georgiana K Ellis; Julie R Gralow; M A Williams; R White; C McGuirt; B B Adamkiewicz; C A Long
Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1395-400.
1997: Robert B Livingston; R Tsuchiya; M Fukushima; Charles A Coltman
Summary of the proceedings of the United States-Japan lung cancer clinical trials summit. Maui, Hawaii, 24-25 February 1996.
Journal of cancer research and clinical oncology 1997;123(8):461-6.
1997: Celestia S Higano; John J Crowley; R V Veith; Robert B Livingston
A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.
Investigational new drugs 1997;15(2):153-6.
1996: L B Tyshler; Gary Longton; Georgiana K Ellis; Robert B Livingston
False positive tumor markers: elevation in patients with breast cancer on FAC-type chemotherapy and correlation with the development of hand-foot syndrome.
The International journal of biological markers 1996;11(4):203-6.
1996: K J Hunt; Gary Longton; M A Williams; Robert B Livingston
Treatment of malignant mesothelioma with methotrexate and vinblastine, with or without platinum chemotherapy.
Chest 1996;109(5):1239-42.
1994: Robert B Livingston
Current management of unresectable non-small cell lung cancer.
Seminars in oncology 1994;21(5 Suppl 10):4-11; discussion 11-3.
1994: Robert B Livingston
Dose intensity and high dose therapy. Two different concepts.
Cancer 1994;74(3 Suppl):1177-83.
1993: Kathy S Albain; John J Crowley; Laura F Hutchins; David R Gandara; R M O'Bryan; Daniel Von Hoff; B Griffin; Robert B Livingston
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
Cancer 1993;72(4):1184-91.
1993: Thomas Buchholz; Mary Austin-Seymour; Roger E Moe; Georgiana K Ellis; Robert B Livingston; J G Pelton; TW Griffin
Effect of delay in radiation in the combined modality treatment of breast cancer.
International journal of radiation oncology, biology, physics 1993;26(1):23-35.
1993: Robert A Chapman; J Crowley; J G Lucas; B L Hom; Robert B Livingston; C B Vaughn; H E Hynes
Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: a Southwest Oncology Group study.
Investigational new drugs 1993;11(1):91-2.
1993: G Ellis; Robert B Livingston
Feasibility of dose-intensive continuous 5-fluorouracil, doxorubicin, and cyclophosphamide as adjuvant therapy for breast cancer.
Cancer 1993;71(2):392-6.
1991: Kathy S Albain; John J Crowley; M LeBlanc; Robert B Livingston
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1618-26.
1991: Kathy S Albain; John J Crowley; Robert B Livingston
Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
Chest 1991;99(6):1425-32.
1991: M W Brunvand; C Collins; Robert B Livingston; Ganesh Raghu
Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma.
Cancer 1991;67(9):2407-9.
1990: JM Cain; Georgiana K Ellis; C Collins; Benjamin E Greer; Hisham Tamimi; D C Figge; Allen M Gown; Robert B Livingston
Bone marrow involvement in epithelial ovarian cancer by immunocytochemical assessment.
Gynecologic oncology 1990;38(3):442-5.
1990: Kathy S Albain; John J Crowley; M LeBlanc; Robert B Livingston
Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(9):1563-74.
1989: G K Ellis; S Green; S Schulman; B L Tranum; R S Goldberg; Robert B Livingston
Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group Study.
Cancer 1989;64(12):2409-15.
1989: Robert B Livingston
Stage IV non-small-cell lung cancer: the guides are perplexed.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1591-3.
1989: G Ellis; M Ferguson; E Yamanaka; Robert B Livingston; Allen M Gown
Monoclonal antibodies for detection of occult carcinoma cells in bone marrow of breast cancer patients.
Cancer 1989;63(12):2509-14.
1989: C Collins; J Mortimer; Robert B Livingston
High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies.
Cancer 1989;63(2):228-32.
1989: C S Higano; Robert B Livingston
Oral dipyridamole and methotrexate in human solid tumors: a toxicity trial.
Cancer chemotherapy and pharmacology 1989;23(4):259-62.
1989: C Collins; C S Higano; Robert B Livingston; B R Griffin; M D Keppen; T P Miller
Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Cancer chemotherapy and pharmacology 1989;24(2):128-32.
1988: Robert B Livingston
Treatment of advanced non-small cell lung cancer: the Southwest Oncology Group experience.
Seminars in oncology 1988;15(6 Suppl 7):37-41.
1988: B R Griffin; Robert B Livingston; G R Stewart; C Higano; Kenneth J Russell; TW Griffin; George E Laramore
Prophylactic cranial irradiation for limited non-small cell lung cancer.
Cancer 1988;62(1):36-9.
1987: Robert B Livingston; B R Griffin; C S Higano; George E Laramore; S E Rivkin; R S Goldberg; S F Schulman
Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(11):1716-24.
1987: Robert B Livingston; S Schulman; B R Griffin; B L Tranum; S E Rivkin; R S Goldberg; C J Fabian; N Hammond; H Hynes
Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.
Cancer 1987;59(7):1249-54.